Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Oct 20;18(10):e0276038. doi: 10.1371/journal.pone.0276038

Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France

Pauline Penot 1,2,*, Julie Chateauneuf 1,3, Isabelle Auperin 4, Hugues Cordel 5, Valerie-Anne Letembet 1, Julie Bottero 5, Johann Cailhol 5
Editor: Ali B Mahmoud6
PMCID: PMC10588853  PMID: 37862300

Abstract

The burden of the first year of the coronavirus disease 2019 (COVID-19) pandemic was greater for vulnerable populations, such as immigrants, people living in disadvantaged urban areas, and people with chronic illnesses whose usual follow-up may have been disrupted. Immigrants receiving care for HIV in Seine-Saint-Denis’ hospitals have a combination of such vulnerabilities, while nonimmigrant people living with HIV (PLWHIV) have more heterogeneous vulnerability profiles. The ICOVIH study aimed to compare the socioeconomic effects of the COVID-19 crisis as well as attitudes toward COVID-19 vaccination among immigrant and nonimmigrant PLWHIV. A questionnaire assessed vulnerabilities prior to the COVID-19 epidemic and the impact of the early epidemic on administrative, residential, professional, and financial fields. We surveyed 296 adults living with HIV at four hospitals in Seine-Saint-Denis, the poorest metropolitan French department, between January and May 2021. Administrative barriers affected 9% of French-born versus 26.3% of immigrant participants. Immigrants experienced financial insecurity and hunger more often than nonimmigrant participants (21.8% versus 7.1% and 6.6% versus 3%, respectively). Spontaneous acceptance of vaccination was higher among nonimmigrant than among immigrant participants (56.7% versus 32.1%), while immigrants were more likely to wait for their doctor’s recommendation or for their doctor to convince them than their French-born counterparts (34.2% versus 19.6%). The trust-based doctor‒patient relationship established through HIV follow-up appeared to be a determining factor in the high acceptance of the COVID-19 vaccine among immigrant participants.

Introduction

Individuals who are born foreigners abroad and reside in France are defined by the French High Council for Integration as immigrants: in France, as elsewhere in Europe [13], immigrants were the most hard hit by coronavirus disease 2019 (COVID-19). During the first wave, both seroprevalence and mortality data confirmed a greater COVID-19-related risk among immigrants: COVID-19 seroprevalence was 9.4% among people born outside Europe compared to 4.1% in the overall French population [4]. The excess overall mortality rate was 114% among people born in sub-Saharan Africa compared to 22% among people born in France in March and April 2020 [5]. Moreover, since they were more likely than nonimmigrants to be in a disadvantaged situation prior to the epidemic, immigrants suffered more from the social and psychological consequences of the crisis [6, 7].

Seine-Saint-Denis, located in the northeastern suburbs of Paris, is the department with the highest rate of immigration and the highest rate of poverty in mainland France [8]. Therefore, the consequences of the COVID-19 crisis have been considerable in this department: the first epidemic wave led to an excess overall mortality rate of 124% between 1 March and 30 April 2020 compared to the same period in 2019. This excess rate was higher than that in Paris despite the Seine-Saint-Denis population being younger [9]. Immigrants, especially those from sub-Saharan Africa, are more affected by HIV and migration, and COVID-19 and HIV might well constitute a new syndemic [10, 11].

Concerns have also been raised about people living with HIV (PLWHIV) not being receiving timely and equitable access to health care [12, 13]. However, to date, little is known about the specific social impacts of the COVID-19 pandemic on PLWHIV, especially those with social vulnerabilities [14, 15]. In our respective HIV clinics, we observed an increasing number of immigrant patients who had lost their employment, experienced overcrowding or loss of housing and fallen into poverty, as reported elsewhere [16, 17].

Attitudes of PLWHIV toward COVID-19 vaccination are also poorly documented and inconsistent: older PLWHIV were more likely to report an intention to vaccinate in studies conducted in the USA [18], Nigeria [19] and Canada [20], but not in a cohort of men having sex with men (MSM) from China, in which concern about disclosure of HIV status was one of the top reasons not to initiate COVID-19 vaccination [21], nor in an Indian cohort, in which lack of confidence in common sources of vaccine-related information, including doctors, emerged as the key parameter in vaccine reluctance [22]. French immigrants have been shown to be more reluctant to receive the COVID-19 vaccine (first-generation African/Asian immigrants OR = 1.16 (95% CI: 1.04–1.30)) [23]. Thus, to our knowledge, vaccine hesitancy has not yet been compared between immigrant and nonimmigrant PLWHIV.

The ICOVIH study aimed to compare the socioeconomic effects of the COVID-19 crisis as well as attitudes toward COVID-19 newly marketed vaccines among immigrant and nonimmigrant PLWHIV.

Methods

We established a questionnaire that mainly covered the domains of essential needs (housing, employment, income, administrative status for immigrants). From January 5 to June 1, 2021, the ICOVIH study (“Impact de la crise COVID-19 sur les personnes vivant avec le VIH”) was conducted among PLWHIV followed up at four public hospitals in Seine-Saint-Denis (André Grégoire Hospital in Montreuil, Avicenne Hospital in Bobigny, Jean Verdier Hospital in Bondy, Delafontaine Hospital in Saint-Denis). Eligible patients were over 18 years old and on antiretroviral therapy before the COVID-19-related first lockdown in France in March 2020. The sample was calculated on the hypothesis that immigrants living with HIV were twice as impacted financially by the COVID-19 crisis compared to nonimmigrants living with HIV and that 20% of nonimmigrants experienced a financial impact. The sample size needed was 214. Medical doctors in charge of patients were asked to propose the survey to their patients at each planned medical visit during the study period. Upon patient acceptance, the survey was administered on the spot and face-to-face or later over the phone, depending on the patient’s choice. Surveys were conducted by trained interviewers. Data were collected anonymously in the Sphinx©IQ2 database (Le Sphinx, Chavanod, France). Information collected consisted of demographic, administrative situation, COVID-19 administrative and financial impact, employment status, housing difficulty, and acceptability of COVID-19 vaccine variables (the variables are presented in detail in S1 Appendix in English and S2 Appendix in French). Immigrant and nonimmigrant participant data were compared using chi-squared or Fisher’s exact tests for categorical variables and the Mann–Whitney U test for continuous variables. All analyses were performed using STATA©12.2 (StataCorp, College Station, TX, USA) software.

Ethical considerations

Medical doctors informed patients about the study objective during their routine follow-up visits. Clarity was sought about participants’ full understanding of the survey and their freedom to consent or not. Patients were aware that their refusal to participate would not affect their quality of care and that they were free to not answer all questions and to withdraw from the survey at any time.

The French Data Protection Authority (CNIL registration number 118512–1610969239) and the André Grégoire Hospital ethics committee (IRB10022022) both approved this project.

Results

Sociodemographic characteristics of immigrant and nonimmigrant participants

The full active file included 1735 PLWHIV. Of these, 1206 were seen at least once during the study period, among whom 380 were offered to participate and 298 accepted (25%). Because of inconsistent data that could not be corrected due to the anonymous data collection process, two participants were subsequently excluded from the analysis. Finally, 296 patients were included in the analysis, of whom 197 were born abroad and 99 were born in France.

When compared to the characteristics of the entire cohort of the participating hospitals, male participants of the ICOVIH study were less likely to be born abroad than those from the overall cohort (50.6% versus 60.9% for the overall PLWHIV cohort). Conversely, no difference was observed in terms of age or geographical origin between women in the ICOVIH study and women from the overall cohort.

Most immigrants were from Western Africa (42.7%) and Central Africa (32.0%). Among immigrant participants, 38.1% had a 10-year residence permit, while 5.1% remained undocumented. Most of the immigrants (81.7%) had been in France for more than 7 years (median length of stay 18 years, interquartile range 9–25 years; Table 1). Only four participants had been in France for less than 2 years.

Table 1. Characteristics of immigrant PLWHIV compared to those born in France, 2021, Seine-Saint-Denis, France.

Immigrants (n = 197) Individuals born in France (n = 99) P
Sex
    Women 112 (56.8%) 16 (16.2%)
    Men 85 (43.2%) 83 (83.8%) < 0.001
Age (years)
    Overall 48 [41–56] 56 [49–61] < 0.001
    Women 47 [40–55] 54 [47–60] 0.010
    Men 48 [43–57] 56 [49–61] < 0.001
Men’s sexual orientation
    MSM 13 (15.7%) 56 (68.3%) < 0.001
    Heterosexual men 70 (84.3%) 26 (31.7%)
Place of birth
    France (metropolitan) NA 88 (88.9%)
    France (overseas) NA 11 (11.1%)
    Europe (outside France) 8 (4.1%)
    Western Africa 84 (42.7%)
    Central Africa 63 (32.0%)
    Eastern Africa 3 (1.5%)
    North Africa 14 (7.1%)
    Non-French Caribbean 13 (6.6%)
    North America 1 (0.5%)
    South America 4 (2.0%)
    Asia 5 (2.5%)
Length of stay in France** (years) 18 [9–25] NA
    < 7 years 34 (18.3%) NA
    > = 7 years 152 (81.7%) NA
Administrative status
    French citizenship 44 (22.3%) 99 (100%)
    European Union or UK citizenship 7 (3.6%)
    10-year residence card 75 (38.1%)
    1-to-5-year residence permit 44 (22.3%)
    Short residence permit (<1 year) 17 (8.6%)
Undocumented 10 (5.1%)
COVID-19 administrative impact
    None 145 (73.7%) 90 (91%) 0.001
    Delay in residence permit 31 (15.7%) NA NA
    Delay in family reunification procedure 3 (1.5%) NA NA
    Delay in application for a social welfare 11 (5.6%) 7 (7.1%)
    Delay in naturalization-civil status document 5 (2.5%) 1 (1%)
    Delay in professional training or diploma 2 (1.0%) 1 (1%)
Current housing difficulties
    None 138 (70.1%) 92 (92.9%) <0.001
    Loss of housing since March 2020 3 (1.5%) 0 (0%)
    Late payment of rent 38 (19.3%) 0 (0%)
    Overcrowding due to loss of housing by others 3 (1.5%) 0 (0%)
    Delay in housing application due to COVID-19 10 (5.1%) 7 (7.1%)
    > = 1night in the street since March 2020 5 (2.5%) 0 (0%)
Household: Who do you live with?
    No one 50 (25.4%) 42 (42.4%) <0.001
    Roommates/co-residents/variable 2522 (12.7%) 434 (4.0%)
    Partner only 22 (11.2%) 34 (34.4%)
    Children +/- partner 85 (43.1%) 7 (7.1%)
    Other family member 15 (7.6%) 12 (12.1%)
Employment status
    Stable contract or activity 75 38.1%) 42 (42.4%) <0.001
    Unstable job, student, crisis-related reduction of working hours 64 (32.4%) 111 (11.1%)
    Job loss since March 20 8 (4.1%) 8 (8.1%)
    Unemployed since before the crisis 37 (18.8%) 10 (10.1%)
    Retired, disabled or on long illness leave 13 (6.6%) 28 (28.3%)
COVID-19-related financial impact
    No impact 93 (47.2%) 59 (59.6%) <0.001
    Improved financial situation 9 (4.6%) 15 (15.15%)
    Loss of income without insecurity 39 (19.8%) 15 (15.15%)
    Loss of income leading to financial insecurity 43 (21.8%) 7 (7.1%)
    Loss of income leading to hunger 13 (6.6%) 3 (3.0%)

Data are presented as n (%) or medians [interquartile ranges]

**11 missing data points; NA: not applicable

Compared to nonimmigrants, immigrant participants were significantly more likely (i) to be women (56.8% versus 16.2%, p < 0.001) and (ii) to be younger (median age 48 versus 56 years, p < 0.001). Only one woman surveyed was pregnant during the first year of the pandemic, and she was an immigrant. MSM were far more represented among men born in France than among those born abroad (68.3% versus 15.7%). Household composition was significantly different in the two groups: immigrant participants were less likely to live alone (25.4% versus 42.4%) or only with their spouse (11.2% versus 34.4%) than their French-born counterparts. Conversely, immigrant participants lived more often with their partner and children (21.8% versus 4.1%) or with their children only (21.3% versus 3.0%). Unemployment prior to the pandemic and unstable jobs (short contract or temporary work) were more frequent in the immigrant group. Being younger, immigrant participants were less likely to be retired (3.5% versus 18.2%), to be disabled or to be on long sickness leave (3.1% versus 10.1%). Immigrants were significantly more likely to report current housing difficulties than nonimmigrants (29.9% versus 7.1%). A delay in paying rent was reported by 19.3% of immigrant participants and by no participant born in France.

Data not presented here were also collected on the psychological impact of COVID in these two populations of PLHIV, and on changes in the consumption of drugs during the first wave. To summarize, feelings of discouragement and expression of suicidal ideation were equally distributed between immigrant and nonimmigrant participants, while increasing, maintaining or withdrawing from drug consumption was a question almost exclusively relevant to participants born in France, as only 4 out of 196 immigrant participants declared a history of drug use.

Impact of the COVID-19 pandemic on both groups

The administrative, financial and housing burdens related to COVID-19 were far heavier among immigrant than among nonimmigrant participants. Administrative barriers affected 9% of French-born participants versus 26.3% of immigrants. For the latter group, administrative issues were mostly related to their foreign status (e.g., delay in obtaining or renewing a residence permit (15.7%)), whereas HIV-positive status was supposed to entitle the holder to legal residency in France for most countries of origin. In contrast, pandemic-related processing delays of a social housing application affected both groups (5.6% of immigrants versus 7.1% of nonimmigrants, Table 1).

COVID-19-related financial deprivation disproportionally affected immigrant participants, who experienced financial insecurity or even hunger more often than nonimmigrant participants (21.8% versus 7.1% and 6.6% versus 3%, respectively). Conversely, 15.1% of French-born participants declared an improvement in their financial situation, either because their incomes increased or because their expenses decreased, while such improvement was only reported by 4.6% of immigrant participants.

A COVID-19 crisis-related reduction in working hours was significantly more frequent among immigrant than among nonimmigrant participants (8.1% versus 2.0%). The small size of this category led us to group it together with unstable jobs, studies and training to compare similar employment situations among immigrant and French-born participants (Table 1). Job loss since the beginning of the crisis was more common among French-born than among immigrant participants (8.0% versus 4.1%, p < 0.001 for overall differences in employment).

Immigrant participants experienced loss of housing (1.5%), overcrowding due to loss of housing by others (1.5%) and nights spent in the street (2.5%), while no French-born participant reported any of those situations during the COVID-19 crisis period.

COVID-19 vaccine acceptance among immigrant and nonimmigrant participants

Although overall acceptance of the COVID-19 vaccine was not significantly higher in the French-born group (73.3% versus 66.3%; Table 2), the conditions for adherence and reasons for refusal were substantially different. Spontaneous acceptance was higher among nonimmigrants (56.7% versus 32.1% among immigrant participants), while immigrants were far more likely to wait for their doctor’s recommendation or for their doctor to convince them (34.2% versus 19.6% among French-born participants). Immigrants were also more anxious about side effects, either related (4.9% versus 1.0%) or unrelated (6.5% versus 0) to their HIV status than nonimmigrants. In both groups, the proportion of participants who postponed their potential vaccination was similar, but again, the motivations were different: three participants specified that they were waiting for a traditional vaccine technology (protein vaccine). All three were MSM born in France, while the 36 immigrants and 16 nonimmigrants remaining were not confident and waited for more information on vaccines. Self-perception of COVID-19 risk was high in both groups, with only 2.7% of immigrant and 3.1% of nonimmigrant participants considering their good compliance with barrier measures to be sufficient.

Table 2. Acceptability of the COVID-19 vaccine among immigrant participants compared to those born in France, 2021, Seine-Saint-Denis, France.

Immigrants (n = 184*) Individuals born in France (n = 97*) P
Overall acceptability
    Yes 122 (66.3%) 74 (76.3%)
    No 62 (33.7%) 23 (23.7%) 0.083
Acceptance
    Spontaneously 59 (32.1%) 55 (56.7%)
    On medical recommendation 63 (34.2%) 19 (19.6%) 0.001
    No because of fear of the vaccine 57 (31.0%) 20 (20.6%)
    No because of low self-perception of risk 5 (2.7%) 3 (3.1%)
Detailed conditions for acceptance
Vaccination already started 6 (3.3%) 6 (6.2%)
    Immediately, without hesitation 53 (28.8%) 49 (50.5%)
    Only if my doctor recommends it 25 (13.6%) 10 (10.3%)
    Only if my doctor convinces me by answering all my questions and explaining why I should receive the vaccine 38 (20.6%) 9 (9.3%)
    No, I am afraid of the side effects because of my HIV 9 (4.9%) 1 (1.0%) 0.001
    No, I am afraid of the side effects, but it has nothing to do with my HIV 12 (6.5%) 0 (0%)
    No, because I adhere to barrier measures very well and I believe that they are sufficient 5 (2.7%) 3 (3.1%)
    I will consider vaccination when more information or other vaccine options are available 36 (19.6%) 19 (19.6%)

Data are presented as n (%) or medians [interquartile ranges]; *Data were collected from the 16th participant.

Factors associated with COVID-19 vaccine acceptance

Spontaneous vaccine uptake, when compared with vaccine hesitancy (refusal or depending on physician’s recommendations or explanations), was significantly more common among MSM (univariate regression odds ratio (OR) 3.85, confidence interval (CI) [2.04–7.25]), even after adjustment for other characteristics, including age and place of birth (multivariate adjusted OR (aOR) 2.53 [1.17–5.44]). Spontaneous acceptance was also associated with age, with PLWHIV over 60 being more likely to seek vaccination spontaneously (multivariate aOR 2.23 [1.19–4.18]).

In univariate analysis, immigrants were less likely to seek vaccination spontaneously (OR 0.36 [0.22–0.60]), and this association might have been in part related to their younger age, as it did not remain significant after adjustment for other characteristics (aOR 0.58 [0.31–1.08]). A history of COVID-19 infection also tended to be associated with spontaneous vaccine uptake after adjustment for age.

A multinomial regression model was run to compare both vaccine refusal and vaccine adherence subject to a doctor’s advice with spontaneous recourse to vaccination (reference category). Immigrants were more likely to accept vaccination on medical advice than to seek it spontaneously (aOR 2.41 CI [1.13–5.17], Table 3). Conversely, immigrants did not have a higher rate of vaccine refusal. Women tended to rely more on medical recommendations than on information obtained by themselves in deciding to get vaccinated, although the small sample size did not allow us to show a significant sex difference between spontaneous and doctor-mediated vaccination uptake. Older participants were less likely to refuse vaccination than to seek it spontaneously (OR 0.37 CI [0.16–0.87]). Finally, participants who had had early COVID-19 were more likely to seek vaccination spontaneously than on medical recommendation (OR 0.37 CI [0.14–0.97]).

Table 3. Patient characteristics by acceptability of the COVID-19 vaccine, Seine-Saint-Denis, 2021 (multinomial model).

Spontaneous vaccine uptake (n = 114) Acceptability conditional upon medical recommendation/explanation (n = 82) Refusal (n = 85)
  OR OR [95% CI] OR [95% CI]
Place of birth
    France Ref. Ref.  Ref.
    Abroad Ref 2.41 [1.13–5.17] 1.80 [0.87–1.71]
Sex
    Men Ref. Ref. Ref.
    Women Ref. 1.94 [1.00–3.77] 1.70 [0.89–3.27]
Age (years)
    < 60 Ref. Ref. Ref.
    > = 60 Ref. 0.60 [0.26–1.35] 0.37 [0.16–0.87]
Year of HIV diagnosis
    1996 or before Ref. Ref. 1.00
    After 1996 Ref. 0.50 [0.22–1.12] 0.68 [0.30–1.51]
COVID-19 infection prior to survey
    No or unknown Ref. Ref. Ref.
    Yes (confirmed or suspected) Ref. 0.37 [0.14–0.97] 0.65 [0.28–1.53]
Employment situation
    Unemployed, retired or student Ref. Ref. Ref.
    Employed Ref. 1.43 [0.73–2.81] 1.19 [0.62–2.27]
Housing
    Personal accommodation Ref. Ref. Ref.
    Hosted or homeless Ref. 1.31 [0.65–2.63] 1.55 [0.78–3.08]

Discussion

Socioeconomic impacts of COVID-19 on immigrant and nonimmigrant PLWHIV

Immigrants from the ICOVIH study experienced more negative effects from the COVID-19 crisis than nonimmigrant participants. These effects were multidimensional: deterioration of housing conditions, decrease in income and hunger. In addition, immigrant participants were affected by administrative issues related to their foreign status, which, by definition, French-born individuals did not encounter. We therefore found among PLWHIV, as in other groups, the deepening of inequalities with the crisis [7], which was also shown in Canada [11]. It is concerning that while most immigrants had been settled in France for more than 7 years, which is considered the necessary time to obtain proper housing, employment and residency permits [24], they were so hard hit by the crisis, as shown in our study. This means that even when immigrants are considered to be settled down, they are in a less stable situation than nonimmigrants.

In line with epidemiological data on PLWHIV in France, in the Seine-Saint-Denis department, the characteristics of PLWHIV groups differed according to their country of origin: PLWHIV born in France were more often MSM, whereas immigrant PLWHIV were mostly women born in sub-Saharan Africa and heterosexual men living in more difficult socioeconomic conditions [25, 26]. The characteristics of ICOVIH participants were similar to those of the overall cohort of PLWHIV in the participating hospitals regarding the sex proportion. However, the distribution of geographical origins was different among male participants who were less likely to be born abroad. This difference reflects the overrepresentation of French-born MSM among the patients followed by one of the medical doctors.

Immigrant PLWHIV in our sample were younger than French-born PLWHIV. This partly explains differences in household composition, with immigrants living more frequently with children than nonimmigrants. We could hypothesize that among previously officially unemployed participants, many relied on informal employment. However, during the lockdown, outdoor circulation was authorized only with official documentation such as employer letters, and informal employment was halted. Short-term contracts were also the first contracts to not be renewed. These latter points explain why more immigrants lost income [27]. Moreover, with immigrants constantly having children at home during the lockdown (and not in schools where children could at least have lunch), their food expenditures increased and sometimes led to hunger [28]. Housing density was also one of the factors that contributed to higher COVID-19 exposure, and our sample truly reflected the social vulnerability of this population to an airborne epidemic.

At the Avicenne and Jean Verdier hospitals, a crisis support team was set up as soon as the lockdown started. Members of this team contacted PLWHIV in their cohorts by phone if they met certain vulnerability criteria. They proposed various types of support: COVID-19 advice, orientation toward nonclosed associations, treatment counseling, and food vouchers [29]. Ikambere, an association based in Seine-Saint-Denis, offers comprehensive support to HIV-positive immigrant women to break the isolation caused by a combination of HIV and precariousness. During the first year of the COVID-19 pandemic, the association faced a dramatic increase in requests related to food aid, housing insecurity, and the breaking of precarious work contracts or rights by its beneficiaries. Thanks to the financial support of private partners, Ikambere increased its distribution of food packs, released emergency financial aid and provided refuge for women who left or had to leave their accommodations. The association then set up an information campaign on vaccination and accompanied beneficiaries to vaccination centers [30]. The results of the ICOVIH survey led to strengthened ties between Montreuil Hospital and Ikambere: an office is now set up one day a week next to the medical consultation rooms to enable HIV-positive immigrant women to meet with a mediator from the association after seeing their doctor.

Early vaccine acceptability

COVID-19 vaccine acceptability was slightly higher among French-born participants than among immigrant participants, but the difference was not significant. Surveys on vaccine acceptance usually show higher vaccine hesitancy among immigrant and minority groups than among nonimmigrants [23, 31]. Our results showed that the situation was different among PLWHIV, with high vaccine acceptance in both French-born and immigrant groups. The conditions under which immigrant participants expressed favorable attitudes toward vaccination (if the doctor recommended vaccination or if the doctor convinced them by answering all their questions and explaining why they should be vaccinated) suggest that the relationship of trust with the doctor who cares for a chronic illness was a determining factor in vaccination acceptance in this immigrant population. However, self-perception of the risk of COVID-19 in this HIV-infected population probably favored the acceptance of the doctor’s vaccination recommendation, as shown by the low percentage of participants who considered that good compliance with barrier measures would be sufficient protection against COVID-19. Participants who had had an early COVID-19 infection were more likely to be vaccinated spontaneously than by medical recommendation, as they probably relied on their own experience to make this choice. Older participants were more likely to seek vaccination spontaneously than to refuse it, probably because of a higher self-perceived risk of developing a severe form of COVID-19. Surprisingly, a history of COVID-19 infection also tended to be associated with spontaneous vaccine uptake after adjustment for age (but not for comorbidities, which were not surveyed). This finding contradicts the idea that a patient confident of being immune would be less inclined to be vaccinated. It suggests, instead, that PLWHIV who had COVID-19 during the first year of the pandemic were generally symptomatic and afraid of becoming ill again.

In the general French population, male sex, high socioeconomic status and older age were positively associated with adherence to COVID-19 vaccination [32, 33].

In a study carried out in a cohort of PLWHIV in the Paris region, Vallée et al. estimated COVID-19 vaccine hesitancy to be 29%. No information was available on the participants’ place of birth or socioeconomic conditions. Female sex was associated with vaccine hesitancy in univariate analysis, but sex remained nonpredictive in multivariate analysis, potentially due to the low representation of women in the sample (23%). Age was not associated with COVID-19 vaccine hesitancy. To the statement “I trust the information I receive about the COVID-19 vaccine from my doctor(s)”, 97% of the PLWHIV in the vaccine acceptance group and 75% in the vaccine hesitancy group answered that they did, a significant difference (p < 0.001), making trust in the doctor’s advice a key factor in adherence to vaccination [34].

Health care providers were identified as the most trusted advisors and influencers of vaccination decisions [35]. The central role played by physicians for immigrants with chronic illnesses has been demonstrated in a previous large study involving PLWHIV from Seine-Saint-Denis and neighboring districts [36]. Trust in the health system and in vaccines is possible for immigrants and people living in precarious situations: we can imagine that here, the relationship built up over time with a doctor and a team enables most immigrant PLWHIV to overcome their concerns about a new vaccine, whereas immigrants who are not engaged in care miss this opportunity.

Strengths and limitations

We conducted a cross-sectional, single-department study on a small sample of PLWHIV. The heavy workload faced by infectiologists at the beginning of 2021 made it impossible to systematize the proposal to all PLWHIV seen in consultations over the period. In addition, the anonymous data collection process chosen for this study did not allow us to review incomplete observations, forcing us to exclude data from participants for whom inconsistencies or too much missing data were identified retrospectively. Finally, comorbidities and educational level were not surveyed, whereas such data would have refined the analysis of determinants of vaccine acceptance.

Conclusion

The ICOVIH survey showed the cumulative and multidimensional vulnerability faced by immigrant PLWHIV, who were likely to have already been in disadvantaged situations compared to nonimmigrant PLWHIV, during the first lockdown. This study also showed that HIV-infected immigrants had confidence in the recommendation to vaccinate coming from their physician and in their physician’s explanations: this confidence enabled them to catch up with a vaccination intention rate close to that of PLWHIV born in France. The physician is a privileged source of information, a focal point for people who have a combination of a chronic illness and social vulnerability. For the most vulnerable, the doctor‒patient relationship is crucial, particularly for the implementation of preventive measures. This relationship will be regularly mobilized as viruses emerge and re-emerge and as new mRNA vaccines are developed in response to such emergencies.

Supporting information

S1 Appendix. Impact of the covid crisis on PLWHIV.

(DOCX)

S2 Appendix. Impact de la crise covid sur les PvVIH.

(DOC)

Acknowledgments

The authors thank Agnès Viot, Mélanie Billi, Annabel Desgrées du Loû, Dr Pascal Pugliese, Dr Anaenza Maresca, Dr Frederic Méchaï, Dr Marie Poupard, Dr Nolan Hassold-Rugolino, Dr Julie Figoni, Dr Claire Tantet, Audrey Guerizec, Gwen Hamet, Guy Nielsen and Karna Coulibaly.

Data Availability

All data underlying the reported results are provided in the submitted article and in the supporting information. However, the individual data of participants cannot be shared due to ethical and legal restrictions. The participants are a vulnerable population and the data contain sensitive information about their administrative status, experience of violence, sexuality and health, which can be used to re-identify them. Due to privacy agreements and the nature of our data, ethics committees and the French data protection authority do not allow the data to be made available to the public. All relevant data can be requested from the principal investigator of the study: pauline.penot@ght-gpne.fr or from the hospital carrying out the project, writing to ag.cegidd@ght-gpne.fr.

Funding Statement

The authors received no personal funding for this work. The French AIDS society (Société Française de Lutte contre le Sida) provided trained interviewers' time to this study.

References

  • 1.Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health. 2020. Nov;74(11):964–8. doi: 10.1136/jech-2020-214401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bhala N, Curry G, Martineau AR, Agyemang C, Bhopal R. Sharpening the global focus on ethnicity and race in the time of COVID-19. Lancet Lond Engl. 2020. May 30;395(10238):1673–6. doi: 10.1016/S0140-6736(20)31102-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Disparities in the risk and outcomes of COVID-19 [Internet]. London; 2020. Aug [cited 2022 Mar 18]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/908434/Disparities_in_the_risk_and_outcomes_of_COVID_August_2020_update.pdf [Google Scholar]
  • 4.Warszawski J, Beaumont AL, Seng R, de Lamballerie X, Rahib D, Lydié N, et al. Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort. BMC Infect Dis. 2022. Jan 9;22(1):41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Papon S, Robert-Bobée I. Une hausse des décès deux fois plus forte pour les personnes nées à l’etranger que pour celles nées en France en mars-avril 2020. [Internet]. Insee; 2020 Jul [cited 2022 Mar 18]. Report No.: 198. Available from: https://www.insee.fr/fr/statistiques/4627049 [Google Scholar]
  • 6.Gosselin A, Melchior M, Carillon S, Gubert F, Ridde V, Kohou V, et al. Deterioration of mental health and insufficient Covid-19 information among disadvantaged immigrants in the greater Paris area. J Psychosom Res. 2021. Jul;146:110504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bajos N, Warszawski J, Pailhé A, Counil E, Jusot F, Spire A, et al. Les inégalités sociales au temps du COVID-19. Questions de santé publique-numéro 40. IReSP. 2020. Oct;1–12. [Google Scholar]
  • 8.Chevrot J, Khelladi I, Omont L, Wolber O, Bikun Bi Nkott F, Fourré C, et al. La Seine-Saint-Denis: entre dynamisme économique et difficultés sociales persistantes [Internet]. INSEE; 2020. [cited 2023 Jun 8]. Available from: file:///C:/Users/PPENOT/Downloads/if_ina_114.pdf [Google Scholar]
  • 9.Évolution du nombre de décès entre le 1er mars et le 30 avril 2020− Nombre de décès quotidiens [Internet]. Insee; [cited 2022 Mar 14]. Available from: https://www.insee.fr/fr/statistiques/4500439?sommaire=4487854#tableau-figure2_radio1 [Google Scholar]
  • 10.Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective. AIDS Behav. 2020. Aug;24(8):2244–9. doi: 10.1007/s10461-020-02871-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Etowa J, Hyman I. Unpacking the health and social consequences of COVID-19 through a race, migration and gender lens. Can J Public Health Rev Can Sante Publique. 2021. Feb;112(1):8–11. doi: 10.17269/s41997-020-00456-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ahmed A, Dujaili J, Sandhu AK, Hashmi FK. Concerns of HIV-positive migrant workers in COVID-19 pandemic: A call for action. J Glob Health. 2020. Dec;10(2):020342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Nawej Tshikung O, Calmy A. [HIV and COVID-19: two viral pandemics in interaction]. Rev Med Suisse. 2022. Jan 19;18(764–5):74–80. [DOI] [PubMed] [Google Scholar]
  • 14.Zucman D, Rasnaama A, Majerholc C, Vallée A. The COVID-19 Pandemic and the Migrant Population for HIV Diagnosis and Care Follow-Up: They Are Left Behind. Healthc Basel Switz. 2022. Aug 24;10(9):1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cooley SA, Nelson B, Doyle J, Rosenow A, Ances BM. Collateral damage: Impact of SARS-CoV-2 pandemic in people living with HIV. J Neurovirol. 2021. Feb;27(1):168–70. doi: 10.1007/s13365-020-00928-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kjøllesdal M, Skyrud K, Gele A, Arnesen T, Kløvstad H, Diaz E, et al. The correlation between socioeconomic factors and COVID-19 among immigrants in Norway: a register-based study. Scand J Public Health. 2022. Feb;50(1):52–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gosselin A, Warszawski J, Bajos N, EpiCov Study Group. Higher risk, higher protection: COVID-19 risk among immigrants in France-results from the population-based EpiCov survey. Eur J Public Health. 2022. Aug 1;32(4):655–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Costiniuk CT, Singer J, Needham J, Yang Y, Qian H, Chambers C, et al. Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey. AIDS Behav. 2023. Feb 4;1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Govere-Hwenje S, Jarolimova J, Yan J, Khumalo A, Zondi G, Ngcobo M, et al. Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community. BMC Public Health. 2022. Jun 22;22(1):1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, et al. COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV. J Acquir Immune Defic Syndr 1999. 2021. Feb 1;86(2):200–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zheng W, Sun Y, Li H, Zhao H, Zhan Y, Gao Y, et al. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey. Hum Vaccines Immunother. 2021. Dec 2;17(12):4971–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ekstrand ML, Heylen E, Gandhi M, Steward WT, Pereira M, Srinivasan K. COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns. J Acquir Immune Defic Syndr 1999. 2021. Dec 15;88(5):421–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bajos N, Spire A, Silberzan L, EPICOV study group. The social specificities of hostility toward vaccination against Covid-19 in France. PloS One. 2022;17(1):e0262192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gosselin A, Desgrées du Loû A, Lelièvre E, Lert F, Dray-Spira R, Lydié N, et al. Understanding Settlement Pathways of African Immigrants in France Through a Capability Approach: Do Pre-migratory Characteristics Matter? Eur J Popul Rev Eur Demogr. 2018. Dec;34(5):849–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dray-Spira R, Wilson d’Almeida K, Aubrière C, Marcellin F, Spire B, Lert F, et al. État de santé de la population vivant avec le VIH en France métropolitaine en 2011 et caractéristiques des personnes récemment diagnostiquées. Premiers résultats de l’enquête ANRS-Vespa2. Bulletin Epidémiologique Hebdomadaire-BEH 26–27. 2013. Jul 2;285–92. [Google Scholar]
  • 26.Lert F, Annequin M, Tron L, Aubrière C, Hamelin C, Spire B, et al. Situation socioéconomique des personnes vivant avec le VIH suivies à l’hôpital en France métropolitaine en 2011. Premiers résultats de l’enquête ANRS-Vespa2. Bulletin Epidémiologique Hebdomadaire-BEH 26–27. 2013. Jul 2;293–9. [Google Scholar]
  • 27.Burton-Jeangros C, Duvoisin A, Lachat S, Consoli L, Fakhoury J, Jackson Y. The Impact of the Covid-19 Pandemic and the Lockdown on the Health and Living Conditions of Undocumented Migrants and Migrants Undergoing Legal Status Regularization. Front Public Health. 2020;8:596887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lesay JD. Crise sanitaire: en l’absence de cantines scolaires, les collectivités aux côtés des élèves modestes [Internet]. banque des territoires. 2020. [cited 2022 Mar 28]. Available from: https://www.banquedesterritoires.fr/crise-sanitaire-en-labsence-de-cantines-scolaires-les-collectivites-aux-cotes-des-eleves-modestes [Google Scholar]
  • 29.Le Joubioux C, Tlili R, Boloko A, Mapi Audigé I, Tantet C, Cailhol J. Enquête Parchemins & conséquences de la pandémie sur la santé des personnes migrantes en Seine-Saint-Denis. Maux d’exil numéro 68. 2021. Jun;4–5. [Google Scholar]
  • 30.Hassambay R, Bennis FZ, Rwegera B, Desgrées du Loû A. L’approche communautaire en santé: un levier de protection des personnes vulnérables en temps de crise sanitaire? Les Tribunes de la Santé. Ahead of print; [Google Scholar]
  • 31.Page KR, Genovese E, Franchi M, Cella S, Fiorini G, Tlili R, et al. COVID-19 vaccine hesitancy among undocumented migrants during the early phase of the vaccination campaign: a multicentric cross-sectional study. BMJ Open. 2022. Mar 17;12(3):e056591. doi: 10.1136/bmjopen-2021-056591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Borga LG, Clark AE, D’Ambrosio C, Lepinteur A. Characteristics associated with COVID-19 vaccine hesitancy. Sci Rep. 2022. Jul 20;12(1):12435. doi: 10.1038/s41598-022-16572-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021. Apr;6(4):e210–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Vallée A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 Vaccine Hesitancy among French People Living with HIV. Vaccines. 2021. Mar 24;9(4):302. doi: 10.3390/vaccines9040302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine. 2016. Dec 20;34(52):6700–6. doi: 10.1016/j.vaccine.2016.10.042 [DOI] [PubMed] [Google Scholar]
  • 36.Pourette D. Genre et relation de soin entre soignants et patient-e-s originaires d’Afrique subsaharienne vivant avec le VIH ou ayant une hépatite B chronique. In: PARCOURS: parcours de vie et santé des Africains immigrés en France. La Découverte. Paris; 2017. p. 360. (Recherches). [Google Scholar]

Decision Letter 0

Ali B Mahmoud

10 Apr 2023

PONE-D-22-26796Socio-economic impacts and Covid19 vaccine perception among migrant and non-migrant PLWHIV in Seine Saint Denis, FrancePLOS ONE

Dear Dr. Penot,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 25 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ali B. Mahmoud, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Please amend the manuscript submission data (via Edit Submission) to include author Isabelle AUPERIN, Valerie-Anne LETEMBET.

4. Please amend your authorship list in your manuscript file to include author CEGIDD hospitalier de Montreuil

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: No

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The ICOVIH study compared the socio-economic effects of COVID-19 crisis and attitudes towards COVID-19 vaccination, between migrant and non-migrant PLWHIV in Seine-Saint Denis. As expected, migrants had more social vulnerability than non-migrants. A trust-based doctor-patient relationship established through HIV follow-up appeared as a determining factor in acceptance of COVID-19 vaccination among migrants.

I have a few questions :

1. How did the questionnaire take into account comprehension, language ?

2. How many woman were pregnant and was the proportion different in between groups ? pregnancy or planned pregnancy have been shown to

3. What was the proportion of drug use in the two groups ?

4. How many patients with a history of covid in each group ?

5. Was there any information on the background of the French-born PLHIV besides being born in metropolitan or overseas France ? Could the cultural background have an impact on vulnerability and/or vaccine acceptability.

6. Were depression and other psychological aspects considered ? If not, this should be discussed.

7. The discussion of findings in comparison with Bangladesh (line 217) seems less appropriate than comparing with findings from more similar settings in France, Europe. Consider discussing work from the Paris area (Zucman D, et al. The COVID-19 Pandemic and the Migrant Population for HIV Diagnosis and Care Follow-Up: They Are Left Behind. Healthcare. 2022)

8. Introduction : should end with a clear statement of the study objectives, as in the abstract : to explore differences between migrant and non-migrant PLWHIV regarding the socio-economic effects of the COVID-19 crisis and differences in attitudes towards COVID-19 vaccination.

9. Remove “an ad hoc study carried out among four hospitals in Seine- Saint Denis department”

10. Please give the reference for André Grégoire Hospital ethics committee approval

11. “native French” : suggests that the persons had a French background, which is not necessarily the case presumably. Please use “born in France”.

12. Need to define the cohort. “the whole PLWHIV cohort” line 117 and following : reference ? what is whole cohort, how many in the “whole” cohort the 380 patients? Conversely, no difference was observed in terms of age and geographical origin for women between ICOVIH study participants and women from the entire cohort (data not shown).

The manuscript needs careful English language proofreading. For instance :

1. line 56 “where most migrants settle down” does this mean that the department has the highest migrant population in France ?

2. Lines 66-68 : the second sentence belongs in the previous paragraph Attitudes of PLWHIV towards COVID vaccination are also poorly documented. In our respective HIV clinics, we observed an increasing number of migrant patients who had lost their employment, housing, and who were thrown into poverty.

3. Consider rewording “thrown into” which implies a voluntary action

4. line 83 : antiretroviral therapy

5. Covid19 or COVID-19 : use same spelling throughout

6. line 95 : “Annex” is Appendix

7. Key words: SARS-VOC2

8. significatively = significantly

9. lines 133 and below Unemployment prior to the pandemic and unstable jobs (short contract or temporary worker) were more frequent in the migrant group. Being older, French-native participants better to compare group A vs B and not change in the middle pensioner retired

10. Borne = born , kid.s = children

11. Disabled status

12. Native French French-born,

13. line 160-62 not clear, need to correct the English “were reported by non-French-born participant.”

14. “no French-borne” not French-born

15. line 177 for “further hindsight” ??. Self-perception of COVID risk was high in both groups, with only 2.7% of migrants and 3.1% of non-migrants participants considering their good compliance with shielding measures to be sufficient.

16. Non, I am afraid of the side effects but it has nothing to do with my HIV

17. line 199 “born in sub-Saharan Africa”

18. the association has faced a dramatic increase : remove “has”, the statement is in the past tense

19. Line 238 that= then among migrant participants

20. line 246 : “relationship of trust with the doctor who follows up on (would be clearer to say “cares for” … factor “in the use of” could be replace by “for vaccination acceptance.”

21. line 256 : “migrants who are far from” : write “not engaged in” care

22. line 262 and below : “The survey also revealed incidentally” : does not seem incidental.

23. “a highly stressful situation, into no one should be thrown” : needs rewording

Reviewer #2: Review

General comments:

The manuscript addresses an important issue, the impact of social and migratory determinants on the experience of the Covid-19 crisis by people living with HIV in an understudied key French territory. The sample is large with sufficient power for the planned analysis. The main limitation of this work is that the comparison group (non-migrant people living with HIV) is likely to be heterogeneous and belong to specific populations at risk of HIV, therefore not the best comparator for analysing the social determinants of health. However, this does not detract from the interest and originality of this work. The article has value to be accepted after some minor corrections.

Specific comments:

As the majority of the migrants included have arrived in France a long time ago, I suggest that you use the term “immigrant” instead and that you refer to the definition of the French High Council for Integration.

In general, avoid superlatives (much more often -> more often)

Analysis: Why was a multivariate analysis not conducted to assess which social determinants explained the differences observed between people living with HIV from migrant backgrounds and others?

Title: Reword the title: it is not clear whether the "Socio-economic impacts" are those of Covid-19 or vaccination. Avoid using abbreviations in the title

Abstract:

- Write at least one contextualising sentence before the objective

- Detail the abbreviations the first time they appear

- “prior to COVID” epidemic

- Avoid starting your sentences with a number

- Residential insecurity rather than administrative barriers?

- Food instability is not a classical concept: food insecurity or hunger?

- Avoid superlatives (much more often/much higher, etc.)

- Correct “convince the than »

- “thrown into poverty »

Main :

- 44 Define immigrants et migrants terms

- 45 The statement that immigrants are in a disadvantaged social situation needs to be explained by underlining the heterogeneity of this group

- 66: Please formulate the objective of the work more clearly at the end of the introduction

- 70: Please explain in a few words why the Makasi study material is suitable for this study

- 79: We wonder how the doctors found the time to administer the questionnaires in consultation to all the patients, thank you for clarifying this

- 98: please specify the number of the approval of the ethics committee

- 101: please add percentage (participation rate)

Could the number of patients offered the study be compared to the number of consultations of PLWH over the study period in the participating hospitals?

- 101 & 102: please merge the 2 sentences

- 114: Specify the number of first-time migrants (e.g. under 2 years after arrival)

- 116: please add p

- 122: children alone?

- 129: correct born & specify living with HIV

- Table1: Replace legal situation by Administrative status.

How were the patients with a receipt classified?

Please ensure that the conditions for using comparison tests are met for all variables

The p are not always aligned with the variable name, what does this mean?

Some percentages are shifted downwards

- 137: remove the –

- 144: correct: reported by only reported by

- 148: when you test the difference, is it significant?

- 151: were all reported

- 155: avoid superlatives

- 157: what is the difference between “for their doctor’s recommendation or for their doctor » ?

- 158 : correct born/borne

- 167 : barriers measures

- 169 : born

- 173 very/more

- 175 and

- 220: avoid us

As the questionnaire was administered in French for the majority of participants, the French version could also be added as an attachment

Reviewer #3: The paper addresses an important issue and the comparison between migrant and non-migrant populations. A number of areas could be addressed to improve the paper and strengthen it.

Abstract

This needs extending to include aspects of the contribution of the contribution of the paper.

Introduction

This is limited in scope. You need to give a clear account of the research questions and/or hypotheses of the research. You also need some comprehensive backgrounds of the study.

Literature review

You need to consider what has been written on the topic. covid-19 has been going on for sometime and has attracted significant amount of work. You need to reviews the significant literature related to your topic to establish the gap that you are attempting to fill. At present there is no literature review section. This also to reason why your reference list is fairly short with limited significant covid or HIV research.

Methods

The research design needs elaboration. You need a clear justification of your choice of methods. You also need selection criteria of the sample and their characteristics (demographic, professional...). You could comprehensively discuss the data analysis framework at this point.

The region covered is also narrow.

Findings

These present only descriptive statistics in the form of percentages. Some more complex statistics with correlations and factor analysis will strengthen your data analysis.

Discussion needs to integrate the literature. As you have not done a literature review, the references in the discussion are new and the reader cannot appreciate their actual weight in supporting the discussion since they have not been debated before.

You need to state the policy implications as well as the contribution of the paper. You may also discuss the limitations of the research.

Overall the paper needs significant improvements.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Professor Laurent Mandelbrot, MD

Reviewer #2: Yes: Nicolas Vignier

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 20;18(10):e0276038. doi: 10.1371/journal.pone.0276038.r002

Author response to Decision Letter 0


22 Jun 2023

Reviewer #1:

1. How did the questionnaire take into account comprehension, language?

Professional translators (« Interservice migrants ») were involved whenever the participant's understanding of French or ability to express him/herself in French had been deemed insufficient. The translator then translated the interviewer's questions and answers, in strict confidentiality of the respondent's identity.

2. How many woman were pregnant and was the proportion different in between groups? pregnancy or planned pregnancy have been shown to …?

Unfortunately, we don't have the end of this question, which was cut off in the e-mail I received from PLOS ONE. Since only one participant was pregnant during the first year of the pandemic (a migrant woman), we can therefore confirm that the proportion of pregnant women did not differ between the two groups.

3. What was the proportion of drug use in the two groups?

This is a very interesting question, and we have indeed collected data on drug use in the ICOVIH survey. However, due to the wealth of data collected, we decided to analyze the psychological impact and substance use variables separately, and present them in a second step. In relation to our research question: most of the migrants (192/196) never used drugs in our sample, which does not make this consumption a variable of interest for our present study.

4. How many patients with a history of covid in each group?

Adding together suspected and confirmed cases, 10 COVIDs were reported in the French-born group (10.1%) and 27 in the migrant group (13.7%), the difference is not significant. This information has been added to the revised manuscript.

5. Was there any information on the background of the French-born PLHIV besides being born in metropolitan or overseas France? Could the cultural background have an impact on vulnerability and/or vaccine acceptability?

Unfortunately, we have no information on the cultural background of the participants. In retrospect, we should have collected information on the participants' educational level, which could have served as a first approximation to this background. We have addressed this limitation in a new section entitled "Strengths and Limitations".

6. Were depression and other psychological aspects considered? If not, this should be discussed.

Yes, it's been explored. We have a lot of data on psychological aspects, which will be examined in a separate analysis. Feelings of discouragement and expression of suicidal ideation were equally distributed between migrants and non-migrant participants.

7. The discussion of findings in comparison with Bangladesh (line 217) seems less appropriate than comparing with findings from more similar settings in France, Europe. Consider discussing work from the Paris area (Zucman D, et al. The COVID-19 Pandemic and the Migrant Population for HIV Diagnosis and Care Follow-Up: They Are Left Behind. Healthcare. 2022)

Absolutely: David Zucman has highlighted the increased risk of follow-up discontinuation among migrant PLWHIV. This reference has been added to justify our concerns about PLWHIV not being receiving timely and equitable access to health care during the crisis.

8. Introduction: should end with a clear statement of the study objectives, as in the abstract: to explore differences between migrant and non-migrant PLWHIV regarding the socio-economic effects of the COVID-19 crisis and differences in attitudes towards COVID-19 vaccination.

This has been changed in the revised manuscript.

9. Remove “an ad hoc study carried out among four hospitals in Seine- Saint Denis department”

This has been changed in the revised manuscript.

10. Please give the reference for André Grégoire Hospital ethics committee approval

The reference has been added to the revised manuscript.

11. “native French”: suggests that the persons had a French background, which is not necessarily the case presumably. Please use “born in France”.

The terms have been changed in the revised manuscript.

12. Need to define the cohort. “the whole PLWHIV cohort” line 117 and following: reference? what is whole cohort, how many in the “whole” cohort the 380 patients?

We have clarified the revised manuscript as follows: the full active file included 1735 PLWHIV of whom 1206 were seen at least once during the study period, and the study was proposed to 380 of them.

The manuscript needs careful English language proofreading.

The revised manuscript has been fully proof read by a Springer Nature US-trained editor, ensuring the correct use of field-specific terminology in clear and accurate English.

1- line 56 “where most migrants settle down” does this mean that the department has the highest migrant population in France?

Yes. With 30% of its residents foreign-born in 2015 census, Seine Saint Denis is the departement in mainland France with the highest proportion of immigrants. (Insee Analyses Île-de-France n° 114 - Février 2020). The clarification has been made in the revised manuscript.

2. Lines 66-68: the second sentence belongs in the previous paragraph Attitudes of PLWHIV towards COVID vaccination are also poorly documented. In our respective HIV clinics, we observed an increasing number of migrant patients who had lost their employment, housing, and who were thrown into poverty.

Thank you for this remark: this has been changed in the revised manuscript.

3. Consider rewording “thrown into” which implies a voluntary action

The phrasing has been changed in the revised version

4. line 83: antiretroviral therapy

The wording has been changed as suggested by the reviewer.

5. Covid19 or COVID-19: use same spelling throughout

Wording has been harmonized in the revised manuscript.

6. line 95: “Annex” is Appendix

This has been changed as suggested.

7. Key words: SARS-VOC2

Thank you! This has been corrected to SARS-COV2

8. significantly = significantly

This has been changed as suggested.

9. lines 133 and below Unemployment prior to the pandemic and unstable jobs (short contract or temporary worker) were more frequent in the migrant group. Being older, French-native participants better to compare group A vs B and not change in the middle pensioner retired

This has been reworded in the revised manuscript.

10. Borne = born, kid.s = children

11. Disabled status

12. Native French French-born

13 line 160-62 not clear, need to correct the English “were reported by non-French-born participant.”

Changes have been made as suggested and the revised manuscript has been edited by American Journal Experts.

14. “no French-borne” not French-born

We meant: No participant born in France (zero). This has been reworded in the revised manuscript.

15. line 177 for “further hindsight” ??. Self-perception of COVID risk was high in both groups, with only 2.7% of migrants and 3.1% of non-migrants participants considering their good compliance with shielding measures to be sufficient.

This has been reworded in the revised manuscript.

16. Non, I am afraid of the side effects but it has nothing to do with my HIV

“Non” was corrected to “no” in the revised manuscript.

17. line 199 “born in sub-Saharan Africa”

This has been specified in the revised manuscript.

18. the association has faced a dramatic increase : remove “has”, the statement is in the past tense

This has been reworded in the revised manuscript.

19. Line 238 that= then among migrant participants

This has been reworded in the revised manuscript.

20. line 246 : “relationship of trust with the doctor who follows up on (would be clearer to say “cares for” … factor “in the use of” could be replace by “for vaccination acceptance.”

This has been reworded in the revised manuscript.

21. line 256 : “migrants who are far from” : write “not engaged in” care

This has been reworded in the revised manuscript.

22. line 262 and below : “The survey also revealed incidentally” : does not seem incidental.

The term has been removed from the revised manuscript.

23. “a highly stressful situation, into no one should be thrown”: needs rewording

The sentence has been reworded in the revised manuscript. 

Reviewer#2:

Specific comments:

As the majority of the migrants included have arrived in France a long time ago, I suggest that you use the term “immigrant” instead and that you refer to the definition of the French High Council for Integration.

Migrant has been changed to immigrants and the reference was added to revised manuscript.

In general, avoid superlatives (much more often -> more often)

Superlatives have been removed from the revised manuscript.

Analysis: Why was a multivariate analysis not conducted to assess which social determinants explained the differences observed between people living with HIV from migrant backgrounds and others?

We thank the reviewer for raising this point: the study was initially designed as a simple comparison between two populations of PLWHIV (immigrants/born in France). As a second step, we considered running a regression model to measure the independent impact of each characteristic on the socio-economic damage each population suffered during the first year of the COVID crisis, but we had chosen a range of variables to explore different socio-economic repercussions and it appeared difficult to reduce them into a single binary variable. Moreover, there were strong correlations between those variables (notably administrative impact) and birth in France versus abroad. However, we suggest in the revised manuscript a logistic regression on vaccine adherence, using the explicative variables available through the questionnaire.

Title: Reword the title: it is not clear whether the "Socio-economic impacts" are those of Covid-19 or vaccination. Avoid using abbreviations in the title

We suggest: Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France

Abstract:

Write at least one contextualising sentence before the objective

Two sentences of context have been added to the revised abstract.

Detail the abbreviations the first time they appear

This has been done in the revised abstract.

“prior to COVID” epidemic

Wording has been changed as suggested.

Avoid starting your sentences with a number

We have taken this into account in the revised manuscript: sentences do not begin with a number in the revised manuscript.

Residential insecurity rather than administrative barriers?

Immigrants faced more administrative barriers than French-born patients during the first year of the pandemic (26% versus 9%). They also faced residential insecurity more often that French-born participants (30% versus 7%). These differences are shown in Table 1.

Food instability is not a classical concept: food insecurity or hunger?

The wording has been changed in the revised manuscript.

-Avoid superlatives (much more often/much higher, etc.)

Superlatives were avoided in the revised manuscript.

- Correct “convince the than »

This has been done, thank you.

- “thrown into poverty »

This has been corrected as well.

Main:

- 44 Define immigrants et migrants terms

The term “immigrant” has been defined and the term "migrant" is no longer used.

- 45 The statement that immigrants are in a disadvantaged social situation needs to be explained by underlining the heterogeneity of this group.

This has been done in the revised manuscript.

66: Please formulate the objective of the work more clearly at the end of the introduction

The double objective was made clear at the end of the revised introduction.

70: Please explain in a few words why the Makasi study material is suitable for this study

In agreement with the main investigator of the MAKASI study, we found it simpler to remove the mention of MAKASI study, as the essential needs we collect in this questionnaire are basic data for all social sciences studies.

79: We wonder how the doctors found the time to administer the questionnaires in consultation to all the patients, thank you for clarifying this

Most doctors have delegated the passing of questionnaires to trained interviewers.

98: please specify the number of the approval of the ethics committee

This has been done in the revised manuscript.

101: please add percentage (participation rate). Could the number of patients offered the study be compared to the number of consultations of PLWH over the study period in the participating hospitals?

The overall active file was 1735. 1206 PLWHIV were seen at least once during the study period, representing a participation rate of 25%. Due to the short duration of the study and the high workload of the doctors, the study was offered to 380 patients, amongst whom 298 accepted (298/1206=25%). The participation rate has been added at the beginning of the results presentation.

101 & 102: please merge the 2 sentences

These sentences have been completely rewritten in response to previous comments.

Specify the number of first-time migrants (e.g. under 2 years after arrival)

Length of stay was available for 186 of the 197 immigrants surveyed (11 missing data). Only 4 had been living in France for less than 2 years. This clarification has been included in the revised manuscript.

116: please add p

P-value has been added to the revised manuscript.

122: children alone?

Wording has been changed in the revised manuscript.

129: correct born & specify living with HIV

Thank you, this has been done in the revised manuscript.

Table1: Replace legal situation by Administrative status

Wording has been changed in the revised table and in the revised introduction.

How were the patients with a receipt classified?

They were classified as short-residence permit holders.

Please ensure that the conditions for using comparison tests are met for all variables

We have reduced the number of categories describing employment status and household composition, which were previously too numerous, even when using a Fisher exact test. The difference is also significant when we compare the occurrence of any residential difficulty with none.

The p are not always aligned with the variable name, what does this mean?

Some percentages are shifted downwards

We have corrected the misprints in Table 1. The p-value is now aligned with the first modality for categorical variables and with the variable itself for continuous variables.

137: remove the –

144: correct: reported by only reported by

Those changes have been done in the revised manuscript.

148: when you test the difference, is it significant?

We have reduced the number of categories used to describe the work situation to ensure a robust comparison (cf revised table 1).

157: what is the difference between “for their doctor’s recommendation or for their doctor »?

“…wait for their doctor’s recommendation” refers to the patients who responded “I would only accept if my doctor recommended it.

“…wait for their doctor to convince them” refers to the patients who responded “I could consider vaccination, but only if my doctor convinces me verbally, answering all my questions and explaining why he or she thinks I should be vaccinated.”

151: were all reported

155: avoid superlatives

158 : correct born/borne

167 : barriers measures

169 : born

173 very/more

175 and

220: avoid us

Changes have all been done in the revised manuscript and the manuscript has been edited by American Journal Experts.

As the questionnaire was administered in French for the majority of participants, the French version could also be added as an attachment

The original version has been added as an attachment. 

Reviewer #3:

Abstract

This needs extending to include aspects of the contribution of the paper.

The contributions of the authors are detailed at the end of the revised abstract.

Introduction

You need to give a clear account of the research questions and/or hypotheses of the research. You also need some comprehensive backgrounds of the study.

The introduction has been rewritten in the light of this comment.

Literature review. You need to consider what has been written on the topic. covid-19 has been going on for sometime and has attracted significant amount of work. You need to reviews the significant literature related to your topic to establish the gap that you are attempting to fill. At present there is no literature review section. This also to reason why your reference list is fairly short with limited significant covid or HIV research.

This has been done in the revised version of the manuscript.

Methods

The research design needs elaboration. You need a clear justification of your choice of methods. You also need selection criteria of the sample and their characteristics (demographic, professional...). You could comprehensively discuss the data analysis framework at this point.The region covered is also narrow.

Thank you for these comments. We have carried out this study at a regional level, in a pragmatic research perspective. We are a team of clinical doctors, and we worked on the basis of our active files, which are indeed localized, but 60% of sub-Saharan immigrants live in the “Ile de France” (IDF) region, essentially in the north-eastern quarter of the IDF, where our hospitals are located. Our research design intended to be a pragmatic one. We have checked the difference between the PLWHIV we surveyed and the entire active file of our hospitals.

Findings

These present only descriptive statistics in the form of percentages. Some more complex statistics with correlations and factor analysis will strengthen your data analysis.

We ran a logistic multinomial regression model to compare spontaneous vaccine uptake with vaccine refusal on one side, and acceptance based on the physician's recommendation or explanation on the other side. Immigrants and women LWHIV were more likely to accept vaccine on the recommendation of their doctor, or after being convinced by their doctor's explanations, all other things being equal. These analyses show that the trust relationship with the doctor is decisive for women and immigrants living with HIV to accept a new vaccine.

Conversely, PLWHIV who have had an early COVID-19 infection spontaneously seek vaccination, after adjustment for the other characteristics surveyed. This finding contradicts the idea that a patient confident of being immune would be less inclined to take up the vaccine. It suggests, instead, that PLWHIV who had COVID during the first year of the pandemic were generally symptomatic and afraid of getting ill again.

The new analyses are presented and discussed in the revised version of the manuscript.

Conversely, we decided not to run a regression model on the socio-economic impacts of the first year of the pandemic, as the study design - which aimed at a comparison- included too many socio-economic impact outcomes to reduce the model into a single variable.

Discussion needs to integrate the literature. As you have not done a literature review, the references in the discussion are new and the reader cannot appreciate their actual weight in supporting the discussion since they have not been debated before.

Thank you: we took into account this comment in the revised version of the manuscript.

You need to state the policy implications as well as the contribution of the paper. You may also discuss the limitations of the research

Thank you for these suggestions. The public health implications are now addressed at the end of the discussion and in the conclusion. In addition, a paragraph on the study’s limitations has been added to the revised manuscript.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Ali B Mahmoud

31 Jul 2023

PONE-D-22-26796R1Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, FrancePLOS ONE

Dear Dr. Penot,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ali B. Mahmoud, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The revised manuscript takes into account the reviewers’ suggestion. The English, style and typographic errors have been improved. Most of the questions are addressed, such as the proportions with a history of covid in each group, the administration of questionnaires by trained interviewers, etc. There is a sentence on the study’s weaknesses.

However, a few of the comments still need to be taken into account. They are acknowledged in the response, but no changes are made in the revision. For instance, pregnancy status and drug use, hunger and psychological issues. The reference to Bangladesh was not removed, despite the fact that the issues are quite different from those raised in this study.

The objectives are not stated correctly. The sentence remains informal : “We therefore explored the impact of the COVID-19 pandemic on PLWHIV with a double scope: on the one hand, …and on the other hand...”

Reviewer #2: The authors have satisfacly addressed my comments.

I have only one comment on "Immigrants were 2.4 times more likely to accept [...]" sentence. The odds ratio being ratio of odds, it is not possible to affirm that this multiplies the risk but only that there is a significant association and enriched the manuscript from an analytical and discussion point of view.

The manuscript is in a state of being published

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Prof Laurent Mandelbrot, MD

Reviewer #2: Yes: Nicolas Vignier

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 20;18(10):e0276038. doi: 10.1371/journal.pone.0276038.r004

Author response to Decision Letter 1


17 Aug 2023

Reviewer #1:

The revised manuscript takes into account the reviewers’ suggestion. The English, style and typographic errors have been improved. Most of the questions are addressed, such as the proportions with a history of covid in each group, the administration of questionnaires by trained interviewers, etc. There is a sentence on the study’s weaknesses.

However, a few of the comments still need to be taken into account. They are acknowledged in the response, but no changes are made in the revision. For instance, pregnancy status and drug use, hunger and psychological issues.

Pregnancy status: The pregnancy status of women in both groups is included in the second revision.

Drug use and psychological issues: Indeed, we had responded to these points in the reply to the reviewer, but had not addressed them in the first revision of the manuscript. We have enhanced the second revision with the data on psychological impact and drug use that we provided in the response to the reviewer's initial comments.

Hunger: We realized that the term we had chosen to describe hunger lacked clarity: we have replaced “food insecurity” with "hunger" in the second revision.

The reference to Bangladesh was not removed, despite the fact that the issues are quite different from those raised in this study.

The reference to Bangladesh has been removed from the second revision.

The objectives are not stated correctly. The sentence remains informal : “We therefore explored the impact of the COVID-19 pandemic on PLWHIV with a double scope: on the one hand, …and on the other hand...”

The newly revised introduction ends with the formulation of objectives suggested by the Reviewer in his initial recommendations.

Reviewer #2:

The authors have satisfacly addressed my comments and enriched the manuscript from an analytical and discussion point of view. I have only one comment on "Immigrants were 2.4 times more likely to accept [...]" sentence. The odds ratio being ratio of odds, it is not possible to affirm that this multiplies the risk but only that there is a significant association

We thank the reviewer for this clarification and modify the second revision of the manuscript accordingly.

Decision Letter 2

Ali B Mahmoud

8 Oct 2023

Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France

PONE-D-22-26796R2

Dear Dr. Penot,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ali B. Mahmoud, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The changes have been made in accordance with my comments. The manuscript is then ready for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Prof Laurent Mandelbrot

Reviewer #2: Yes: Nicolas Vignier

**********

Acceptance letter

Ali B Mahmoud

13 Oct 2023

PONE-D-22-26796R2

Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France

Dear Dr. Penot:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ali B. Mahmoud

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Impact of the covid crisis on PLWHIV.

    (DOCX)

    S2 Appendix. Impact de la crise covid sur les PvVIH.

    (DOC)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All data underlying the reported results are provided in the submitted article and in the supporting information. However, the individual data of participants cannot be shared due to ethical and legal restrictions. The participants are a vulnerable population and the data contain sensitive information about their administrative status, experience of violence, sexuality and health, which can be used to re-identify them. Due to privacy agreements and the nature of our data, ethics committees and the French data protection authority do not allow the data to be made available to the public. All relevant data can be requested from the principal investigator of the study: pauline.penot@ght-gpne.fr or from the hospital carrying out the project, writing to ag.cegidd@ght-gpne.fr.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES